Liquid chromatography coupled with high resolution mass spectrometry (LC-HRMS) complements standard triple-quadrupole mass spectrometry in veterinary drug residue control. LC-HRMS offers the opportunity for nontargeted screening for metabolites and biomarkers representing metabolic changes. In this work, the feasibility of a nontargeted metabolomics approach based on LC-HRMS data (LC-Q-Orbitrap and LC-Q-TOF) to distinguish between porcine muscle tissue from infected animals and from healthy animals is demonstrated. The differences arise from various compounds associated with metabolic changes in infected animals. Two new biomarker candidates have been identified: tripeptide prolyphenylalanylglycine and a lysophosphatidylcholine derivative. For the first time, a bivariate data analysis procedure is described that may be used to evaluate whether the presence of antibiotic residues points to a therapeutic application or may be the result of a contamination during sampling and/or analysis.
Keywords: biomarker; contamination; infection; metabolomics; nontargeted LC-HRMS; residue control; veterinary drugs.